NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nitinotes Ltd.

Nitinotes Ltd.

Private
CaesareaHealthcare & Life Scienceshttps://nitinotesurgical.com/

Last Round

SAFE

Dec 23, 2024

Total Funding Raised

$37.94M

Company Overview

Nitinotes Ltd. is a medical device company that develops automated endoluminal suturing technologies for the treatment of obesity.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

endoscopic sleeve gastroplastyESGendoluminal suturingbariatric surgeryminimally invasive surgeryobesity treatmentmedical devicerobotic surgeryendoscopic suturingweight loss surgerygastroenterologysurgical roboticsnon-surgical weight lossbariatric deviceendoscopic procedure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nitinotes Ltd. Comparables

Compare Nitinotes Ltd. with similar companies based on industry and business-model similarity.

Nitinotes Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
USGI Medical
86%
Endo Tools Therapeutics
85%
EnVision Endoscopy
79%

Nitinotes Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SAFEDec 23, 2024
Series BSep 28, 2023
SAFEJul 1, 2022
Series A ExtensionMay 10, 2020
SeedJan 7, 2019
Series A
Jan 7, 2019

Key People

Founding team and executive leadership

Lloyd Diamond

Chief Executive Officer

Executive Team

Raz Bar-On

CTO & Chief Global Support

Executive Team

Offer Nonhoff

CFO

Executive Team

Hagit Ephrath

VP QA, Regulatory and Clinical Affairs, COO

Executive Team

Nitinotes Ltd. Investors

Notable investors and investment history

Nitinotes Ltd. investors
InvestorRounds
Israel Innovation AuthoritySeed
MTIPSeries A, SAFE
Peregrine VenturesSeries A, Seed
AccelmedSeries A, Seed
Elron VenturesSAFE, Series B, Series A, Series A Extension
TechWald HoldingSAFE, Series A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 10, 2020

    $7.1M round with TechWald Holding and Elron Ventures.

  • Jan 7, 2019

    $6.3M round led by Accelmed and MTIP.

Nitinotes Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nitinotes Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nitinotes Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCaesarea
Employee Range34
Year Founded2014
Last FundingDec 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.